Authorization to Use and Disclose Health Information Sample Clauses

Authorization to Use and Disclose Health Information. Principal Investigator will obtain a written privacy authorization, complying with all Applicable Law, for each Trial Subject which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor with completed case report forms (“CRFs”), source documents and all other information required by the Protocol. Sponsor, though not a covered entity, recognizes that, pursuant to this Agreement, it has the responsibility to protect all individually identifiable patient information and to restrict the use of such information to those persons and entities, including consultants, contractors, subcontractors and agents, who must have access to such information in order to fulfill their assigned duties with respect to the Trial. Such use also will be restricted to those permitted in the 10.1 S ouhlas používat a sdělovat zdravotní informace Hlavní zkoušející získá od každého subjektu klinického hodnocení v souladu se všemi platnými zákony písemný souhlas k poskytnutí osobních údajů, který umožní zdravotnickému zařízení a hlavnímu zkoušejícímu poskytnout zadavateli a dalším osobám a subjektům určeným zadavatelem vyplněné formuláře záznamů subjektu (case report forms, CRF), zdrojové dokumenty a všechny další informace požadované dle protokolu. Zadavatel, ačkoliv se nejedná o smluvní stranu, bere na vědomí, že tato smlouva zakládá povinnost chránit všechny individuálně identifikovatelné údaje o pacientech a omezit jejich používání pouze na osoby a subjekty, včetně konzultantů, dodavatelů, subdodavatelů a zmocněnců, které potřebují přístup k těmto informacím pro plnění povinností v souvislosti s klinickým hodnocením. Používání těchto údajů bude omezeno na rozsah povolený souhlasem, a zadavatel ani žádná jiná strana, které zadavatel mohl sdělit individuálně authorization forms and neither Sponsor nor any party to whom Sponsor may disclose individually identifiable health information may use such information to recruit research subjects to additional studies, to advertise additional studies or products, or to perform marketing or marketing research. Institution and Principal Investigator will provide Sponsor or INC Research an opportunity to review and approve the content of the authorization (including any revisions made during the course of the Trial) before it is used. identifikovatelné zdravotní údaje, nesmí tyto informace používat k získávání subjektů výzkumu pro další studie, k propagaci jiných studií, produktů,...

Authorization to Use and Disclose Health Information. Institution shall provide an appropiate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. If such an authorization is separate from the informed consent form (“ICF”), Institution will only use the authorization that is approved by Sponsor, IEC and/or RA (if applicable).

Authorization to Use and Disclose Health Information. Principal Investigator shall provide an appropriate privacy notice to each Trial Subject and obtain a written privacy authorization from each Trial Subject, complying with Applicable Law, which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed CRFs, source documents from specific Trial subjects and all other information required by the Protocol. If such an authorization is separate from the ICF, Principal Investigator will only use the authorization that is prepared by Sponsor, IEC and/or RA (if applicable). 10.1. Souhlas používat a sdělovat zdravotní informaceHlavní zkoušející každý subjekt hodnocení vhodným způsobem upozorní na ochranu osobních údajů a získá od něj písemný souhlas v souladu s platnými zákony písemný souhlas k poskytnutí osobních údajů, který umožní hlavnímu zkoušejícímu, zadavateli a dalším osobám a subjektům určeným zadavatelem přístup k vyplněným formulářům záznamů subjektu („CRF”), zdrojovým dokumentům konkrétních subjektů a všem dalším informacím požadovaných dle protokolu. Není-li tento souhlas uzavřen jako součást formuláře informovaného souhlasu, hlavní zkoušející použije pouze souhlas, který je vypracován zadavatelem, NEK, a/nebo kontrolním úřadem.

Authorization to Use and Disclose Health Information. Institution and Principal Investigator will obtain a written privacy authorization, complying with Applicable Law, for each Trial Subject which will enable Institution and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. Sponsor, though not a covered entity, recognizes that, pursuant to this Agreement, it has the responsibility to protect all individually identifiable patient information and to restrict the use of such information to those persons and entities, including consultants, contractors, subcontractors and agents, who must have access to such information in order to fulfill their assigned duties with respect to the Trial. Such use also will be restricted to those permitted in the authorization forms and neither Sponsor nor any party to whom Sponsor may disclose individually identifiable health information may use such information to recruit research subjects to additional studies, to advertise additional studies or products, or to perform marketing or marketing research. If such an authorization is separate from the ICF, Institution and Principal Investigator will only use such authorization that is approved by Sponsor, IEC (if applicable) and regulatory authority (if applicable).

Authorization to Use and Disclose Health Information. I hereby authorize and direct Audiology Experts to release confidential medical information to any entity, government agency, or insurance carrier in order to secure payment related to services rendered. Audiology Experts may also disclose my health information to the referring physician, family doctor, and school personnel for transfer of medical care, and follow-up purposes.

Authorization to Use and Disclose Health Information. Institution will obtain a written privacy authorization, complying with Applicable Law, for each Trial Subject which will enable Institution to provide Sponsor and other persons and entities designated by 9.1 Povolenie použiť a zverejniť údaje o zdravotnom stave. Inštitúcia získa pre každú Pokusnú osobu písomné formuláre povolenia využitia osobných údajov, ktoré budú v súlade s Príslušnými právnymi predpismi, a ktoré umožnia Inštitúcii poskytovať Sponzorovi a Sponsor with completed Case Report Forms (“CRFs”), source documents and all other information required by the Protocol. Sponsor or INC Research, though not a covered entity, recognizes that, pursuant to this Agreement, it has the responsibility to protect all individually identifiable patient information and to restrict the use of such information to those persons and entities, including consultants, contractors, subcontractors and agents, who must have access to such information in order to fulfill their assigned duties with respect to the Trial. Such use also will be restricted to those permitted in the authorization forms and neither Sponsor or INC Research nor any party to whom Sponsor or INC Research may disclose individually identifiable health information may use such information to recruit research subjects to additional studies, to advertise additional studies or products, or to perform marketing or marketing research. ostatným osobám a subjektom, ktoré určí Sponzor, vyplnené Formuláre správy o prípade („FSP”), zdrojovú dokumentáciu a všetky ostatné informácie vyžadované Protokolom. Sponzor alebo spoločnosť INC Research, ktoré aj napriek tomu, že nie sú povinným subjektom, uznávajú, že podľa tejto Dohody majú zodpovednosť za ochranu všetkých osobne identifikovateľných údajov o pacientoch a za obmedzenie použitia týchto údajov na tie osoby a subjekty (vrátane poradcov, dodávateľov, subdodávateľov a zástupcov), ktorí k nim musia mať prístup, aby mohli plniť svoje stanovené úlohy týkajúce sa Skúšania. Toto používanie sa obmedzí len na tie spôsoby použitia, ktoré budú povolené vo formulároch povolení a ani Sponzor, spoločnosť INC Research, ani žiadna strana, ktorej Sponzor či spoločnosť INC Research môže poskytnúť individuálne identifikovateľné údaje o zdravotnom stave, nesmú využiť tieto údaje na nábor skúmaných osôb do ďalších štúdií, na propagáciu ďalších štúdií či produktov alebo na marketing ▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇.

Authorization to Use and Disclose Health Information. Provider and Principal Investigator will obtain a written privacy authorization, complying with Czech Republic data protection laws and Applicable Law, for each Trial Subject which will enable Provider and Principal Investigator to provide Sponsor and other persons and entities designated by Sponsor access to completed case report forms (“CRFs”), source documents and all other information required by the Protocol. Sponsor, though not a covered entity, recognizes that, pursuant to this Agreement, it has the responsibility to protect all individually identifiable patient information and to restrict the use of such information to those persons and entities, including consultants, contractors, subcontractors and agents, who must have access to such information in order to fulfill their assigned duties with respect to the Trial. Such use also will be restricted to those permitted in the authorization forms and neither Sponsor nor any party to whom Sponsor may disclose individually identifiable health information may use such information to recruit research subjects to additional studies, to advertise additional studies or products, or to perform marketing or marketing research. If such an authorization is separate from the ICF, Provider and Principal Investigator will only use such authorization that is approved by Sponsor, IEC (if applicable) and regulatory authority (if applicable).

Authorization to Use and Disclose Health Information. Institution and Principal Investigator shall provide an appropriate privacy notice to each Trial Subject and obtain a written privacy 10.1

Authorization to Use and Disclose Health Information. Provider and Principal Investigator shall provide an appropriate privacy notice that will be 10.